TY - JOUR T1 - COVID-19 in gastroenterology: a clinical perspective JF - Gut JO - Gut SP - 1144 LP - 1145 DO - 10.1136/gutjnl-2020-321051 VL - 69 IS - 6 AU - John Ong AU - Barnaby Edward Young AU - Sharon Ong Y1 - 2020/06/01 UR - //www.marcconsult.com/content/69/6/1144.abstract N2 - We read with interest the article ‘Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus' by Liang et al.1 Indeed, we agree with the authors that diarrhoea may be an underestimated and under-reported symptom of coronavirus disease 2019 (COVID-19).与中国数据相似, 发烧和咳嗽是新加坡最常报告COVID-19的两种症状约30%的病例为afbrile,这可能是集中联系寻址的结果2 3 对比之下,中国胃肠症似乎不常见(海呕:5.0%和腹泻:3.7%),新加坡17%的COVID-19病人报告腹泻3 。 有意思的是,SARS-COV2RNA检测到50%的病人床样本,但没有明显与腹膜症相关联。有可检测排泄病毒RNA的人中,大约一半有腹泻,一半有正常凳一致性。 除内脏外,研究显示SARS-COV2还影响肝脏4-6